BridgeBio Oncology Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of small-molecule therapeutics for the treatment of renin-angiotensin system and ...

Not a lot going on at the club at present with no tournaments on the horizon. Coming in September, though, is a new set of ...

Nigerian folk singer Segun Akinlolu, popularly known as Beautiful Nubia, has accused gospel artistes Yinka Ayefele and BBO of infringing on the copyright of his song ‘Seven Lifes’. In a post shared on ...

Segun Akinlolu, popularly known as Beautiful Nubia, has publicly accused gospel musicians Yinka Ayefele and a new artiste identified as BBO of allegedly copying the melody of his original song, “Seven ...

Nigerian folk singer Beautiful Nubia has accused gospel musicians Yinka Ayefele and fast-rising act BBO of infringing on the copyright of his classic song Seven Lifes. The folk star, whose real name ...

Thank you for standing by, and welcome to the BBOT Clinical Data Update Call. Today's program is being recorded. [Operator Instructions] I'd now like to introduce your host for today's program, ...

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway ...

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway ...

Mutations in the gene encoding PI3Kα are associated with several types of cancer, but selectively targeting oncogenic signalling while leaving physiological PI3Kα activity intact has proved ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect. The compound was developed by Lawrence Livermore National ...